07:00 AM EDT, 07/25/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lift our 12-month target price by $25 to $155, valuing GL shares at 10x our 2026 operating EPS estimate of $15.50 (up by $1.00), versus the shares' five-year average forward multiple of 10.8x and a peer average of 10x. We also raise our 2025 operating EPS estimate by $0.95 to $14.45 after management guided estimates high on expected reserve releases in Q3 and Q4 amid consistently improved mortality and other underwriting claim trends. We believe the uptick in EPS expectations, GL's success at expanding its agent base (GL's agent count rose 6% sequentially in Q2), and the favorable resolution of the SEC investigation (without any enforcement actions being taken) into allegations of fraud all provide the shares with a catalyst for multiple expansion. At current levels, the shares trade at 9.1x our 2025 EPS estimate and at 8.5x our 2026 EPS estimate, and are undervalued versus peer and historical averages, in our view.